Together with @fspelema & @goossens_lab we are looking for a motivated postdoc to study the tumour-immune microenvironment in neuroblastoma at @ugent & @VIBLifeSciences Deadline for applications is 28th Feb. Apply here: https://t.co/FWu1MAYw5v
THERE’S NO REASON TO VALIDATE YOUR RNA-SEQ EXPERIMENT WITH qPCR. RNA-SEQ IS A FAIRLY UNBIASED APPROACH TO ASSESS TRANSCRIPT QUANTITY ACROSS THE WHOLE GENOME AND DOESN’T SUFFER FROM PROBE BIAS THAT CAN BE EXPERIENCED WITH QPCR PRIMERS
We must be living in the golden age of podcasts!
Thank you for including Night Science in your list of favorite podcasts. https://t.co/Oslrhff2uO @the_Node
Thanks to everyone who supported, inspired, challenged and helped me with this grant application. My research team #TOBIlab, our collaborators, @ugent, @ugent_fge, @crighent, ...
Thanks to everyone who supported, inspired, challenged and helped me with this grant application. My research team #TOBIlab, our collaborators, @ugent, @ugent_fge, @crighent, ...
Our (the first?) zebrafish embryo single-cell open chromatin atlas is out @CellGenomics ! Includes detailed cell-type enhancer candidates as well as new software for scATAC data processing and regulatory state annotations!
I'm so excited to see our review on "Cancer cell states and emergent properties of the dynamic tumor system" now published in @genomeresearch !
https://t.co/JIh6tbJ44c
Our new preprint introducing scCUT&Tag-pro (single-cell profiling of histone modifications and cell surface proteins), scChromHMM (inferring chromatin states in single cells), and an integrated reference of 9 molecular modalities in human PBMC: https://t.co/2ypttjJDRt
Flanders reaches an incredible milestone investing 3.35 % of GDP on R&D, well above the 3% target. Thanks to @vlaamseoverheid, Flanders ranks second in Europe in R&D spend - even surpassing the USA. Come join our vibrant ecosystem! https://t.co/OTF5Qag7p3